Literature DB >> 25438391

WHO targets elimination of TB in over 30 countries.

.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25438391

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN： 1210-7778            Impact factor:   1.163


× No keyword cloud information.
  4 in total

1.  HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.

Authors:  Ken Tashiro; Nobuyuki Horita; Kenjiro Nagai; Misako Ikeda; Masaharu Shinkai; Masaki Yamamoto; Takashi Sato; Yu Hara; Hideyuki Nagakura; Yuji Shibata; Hiroki Watanabe; Kentaro Nakashima; Ryota Ushio; Akimichi Nagashima; Atsuya Narita; Nobuaki Kobayashi; Makoto Kudo; Takeshi Kaneko
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

2.  Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study.

Authors:  Anik R Patel; Jonathon R Campbell; Mohsen Sadatsafavi; Fawziah Marra; James C Johnston; Kirsten Smillie; Richard T Lester
Journal:  BMJ Open       Date:  2017-09-15       Impact factor: 2.692

3.  Factors for Predicting Outcomes among Non-HIV Patients with Pulmonary Tuberculosis.

Authors:  Toshinori Tsukahara; Nobuyuki Horita; Ken Tashiro; Kenjiro Nagai; Masaharu Shinkai; Masaki Yamamoto; Takashi Sato; Yu Hara; Hideyuki Nagakura; Yuji Shibata; Hiroki Watanabe; Kentaro Nakashima; Ryota Ushio; Akimichi Nagashima; Misako Ikeda; Atsuya Narita; Katsuhito Sasaki; Nobuaki Kobayashi; Makoto Kudo; Takeshi Kaneko
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

4.  Estimating the long-term effects of mass screening for latent and active tuberculosis in the Marshall Islands.

Authors:  Romain Ragonnet; Bridget M Williams; Angela Largen; Joaquin Nasa; Tom Jack; Mailynn K Langinlur; Eunyoung Ko; Kalpeshsinh Rahevar; Tauhid Islam; Justin T Denholm; Ben J Marais; Guy B Marks; Emma S McBryde; James M Trauer
Journal:  Int J Epidemiol       Date:  2022-10-13       Impact factor: 9.685
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.